1. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation
   Peter Gál et al, 2022, Histochemistry and Cell Biology CrossRef
2. Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway
   Hee Su Kim et al, 2023, Biomedicines CrossRef
3. Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer
   Rhynelle S. Dmello et al, 2024, Cell Death & Disease CrossRef
4. Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel
   Shengnan Zhang et al, 2023, Molecules CrossRef
5. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
   Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
6. Repurposed Drugs in Gastric Cancer
   Diana Araújo et al, 2022, Molecules CrossRef
7. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer
   Min Wan et al, 2024, Molecular Biotechnology CrossRef
8. The potential role of interleukins and interferons in ovarian cancer
   Huldani Huldani et al, 2023, Cytokine CrossRef
9. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis
   Divya Janjua et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
10. E3 ubiquitin ligase NEDD4L negatively regulates skin tumorigenesis by inhibiting of IL-6/GP130 signaling pathway
    Huan Liu et al, 2024, Journal of Investigative Dermatology CrossRef
11. Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer
    Nina A. Hering et al, 2023, Cancers CrossRef